# Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina

> **NCT00770770** · PHASE2 · TERMINATED · sponsor: **Alimera Sciences** · enrollment: 20 (actual)

## Conditions studied

- Macular Edema
- Retinal Vein Occlusion

## Interventions

- **DRUG:** Fluocinolone Acetonide
- **DRUG:** Fluocinolone Acetonide

## Key facts

- **NCT ID:** NCT00770770
- **Lead sponsor:** Alimera Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05
- **Primary completion:** 2013-10
- **Final completion:** —
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00770770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00770770, "Fluocinolone Acetonide Intravitreal Inserts for Vein Occlusion in Retina". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00770770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
